ECM
BIVV

ETrade Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

ETrade Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-9,163
Closed -$494K – 798
2017
Q4 		$494K Sell
9,163
-1,166
-11% -$63.8K 0.02% 506
2017
Q3 		$589K Buy
+10,329
New +$605K 0.02% 425

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

ETrade Capital Management's BIVV Position: Q1 2018 in Review

ETrade Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 9,163 shares — an estimated $494K sold.

ETrade Capital Management first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $589K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • ETrade Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • ETrade Capital Management sold 9,163 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $494K.
  • ETrade Capital Management first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • ETrade Capital Management's Bioverativ Inc. Common Stock position peaked at $589K in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on ETrade Capital Management's 13F filing for Q1 2018, filed 7 May 2018.